Head to head
Lazard vs Morgan Stanley
Side-by-side on the measures that matter, with a plain-English read. Full detail: LAZ · MS
LAZ
Lazard
35.82-1.49%
1-year price shape — -25% over the period
Quant Rating E · 13/100
vs
MS
Morgan Stanley
189.71-0.69%
1-year price shape — +24% over the period
Quant Rating D · 64/100
1-year performance, rebased to 100
Morgan Stanley edges it on the scoreable measures. Morgan Stanley has the highest Quant Rating (64); Morgan Stanley has done best over the past year (+24%); Morgan Stanley trades cheapest on trailing earnings.
| LAZ | MS | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 35.82 | 189.71 |
| Change today | -1.49% | -0.69% |
| 1-year return | -25.2% | +24.4% |
| Market cap | $3.49B | $297.95B |
| 52-week range | 34.76 – 57.45 | 148.51 – 230.98 |
| Valuation | ||
| P/E (TTM) | 17.65 | 15.32 |
| P/E percentile, own 5-yr range | 68th | 46th |
| P/B | 3.82 | 2.80 |
| Dividend yield | 5.58% | 2.11% |
| Profitability & growth | ||
| EPS (TTM) | 2.17 | 10.21 |
| Net profit (TTM) | $211.47M | $16.04B |
| Revenue (TTM) | $3.28B | $73.05B |
| Revenue growth (YoY) | +1.9% | +27.4% |
| Gross margin | 33.2% | -- |
| Operating margin | 11.1% | -- |
| Net margin | 6.7% | 26.8% |
| Free cash flow (TTM) | $658.76M | $-18.58B |
| Ownership & sentiment | ||
| Institutional ownership | 107.1% | 87.0% |
| Insider activity (12mo) | 35 buy / 15 sell | 23 buy / 27 sell |
| Short interest (% of float) | 10.2% | 0.9% |
| Analyst consensus | 40% buy / 40% hold / 20% sell (5) | 62% buy / 38% hold (13) |
| Analyst price target | $45 (+25%) | $241 (+27%) |
| StockVane view | ||
| StockVane Quant Rating | E (13) | D (64) |
| Company | ||
| Employees | 3,309 | 83,000 |
| Founded | 1848 | 1924 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.